• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Treatment response between Asian and non-Asian patients with type 2 diabetes: is there any similarity or difference?

作者信息

Cai Xiao-Ling, Ji Li-Nong

机构信息

Department of Endocrinology and Metabolism, Peking University People's Hospital, Beijing 100044, China.

出版信息

Chin Med J (Engl). 2019 Jan 5;132(1):1-3. doi: 10.1097/CM9.0000000000000012.

DOI:10.1097/CM9.0000000000000012
PMID:30628952
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6629298/
Abstract
摘要

相似文献

1
Treatment response between Asian and non-Asian patients with type 2 diabetes: is there any similarity or difference?2型糖尿病亚洲患者与非亚洲患者的治疗反应：有相似之处还是差异？
Chin Med J (Engl). 2019 Jan 5;132(1):1-3. doi: 10.1097/CM9.0000000000000012.
2
Effects of linagliptin vs. voglibose on daily glucose excursions during continuous glucose monitoring of Japanese type 2 diabetes patients (L-CGM): A randomized, open-label, two-arm, parallel comparative trial.利格列汀与伏格列波糖对日本2型糖尿病患者持续葡萄糖监测期间每日血糖波动的影响（L-CGM）：一项随机、开放标签、双臂、平行对照试验。
Diabetes Metab. 2017 Dec;43(6):550-553. doi: 10.1016/j.diabet.2017.07.010. Epub 2017 Sep 22.
3
The ACCORD Trial and control of blood glucose level in type 2 diabetes mellitus: time to challenge conventional wisdom.ACCORD试验与2型糖尿病患者血糖水平的控制：是时候挑战传统观念了。
Arch Intern Med. 2009 Jan 26;169(2):150-4. doi: 10.1001/archinternmed.2008.518.
4
Are We There Yet?我们到了吗？
Diabetes Forecast. 2016 Jan-Feb;69(1):52-7.
5
Efficacy and tolerability of exenatide twice daily and exenatide once weekly in Asian versus White patients with type 2 diabetes mellitus: A pooled analysis.每日两次艾塞那肽与每周一次艾塞那肽在亚洲和白人2型糖尿病患者中的疗效及耐受性：一项汇总分析。
Diabetes Res Clin Pract. 2016 Apr;114:160-72. doi: 10.1016/j.diabres.2015.12.004. Epub 2016 Jan 9.
6
A double-blind, placebo-controlled, randomised trial to assess the effect of liraglutide on ectopic fat accumulation in South Asian type 2 diabetes patients.一项评估利拉鲁肽对南亚 2 型糖尿病患者异位脂肪积累影响的双盲、安慰剂对照、随机临床试验。
Cardiovasc Diabetol. 2019 Jul 9;18(1):87. doi: 10.1186/s12933-019-0890-5.
7
Efficacy and safety of saxagliptin added to metformin in Asian people with type 2 diabetes mellitus: a randomized controlled trial.在亚洲 2 型糖尿病患者中，加用沙格列汀对比安慰剂联合二甲双胍的疗效和安全性：一项随机对照试验。
Diabetes Res Clin Pract. 2011 Nov;94(2):217-24. doi: 10.1016/j.diabres.2011.07.035. Epub 2011 Aug 26.
8
Dapagliflozin as monotherapy in drug-naive Asian patients with type 2 diabetes mellitus: a randomized, blinded, prospective phase III study.达格列净单药治疗初治亚洲2型糖尿病患者：一项随机、双盲、前瞻性III期研究。
Clin Ther. 2014 Jan 1;36(1):84-100.e9. doi: 10.1016/j.clinthera.2013.11.002. Epub 2013 Dec 28.
9
Post-prandial carbohydrate modulation via gut--Indian perspective.餐后通过肠道调节碳水化合物——印度视角
J Assoc Physicians India. 2010 Nov;58:665.
10
Response to comment on: Bosi et al. Intensive structured self-monitoring of blood glucose and glycemic control in noninsulin-treated type 2 diabetes: the PRISMA randomized trial. Diabetes Care 2013;36:2887-2894.对关于《博西等人。非胰岛素治疗的2型糖尿病患者强化结构化血糖自我监测与血糖控制：PRISMA随机试验》评论的回复。《糖尿病护理》2013年；36:2887 - 2894。
Diabetes Care. 2013 Dec;36(12):e218. doi: 10.2337/dc13-1683.

引用本文的文献

1
Metformin for the Treatment of Type 2 Diabetes in Asian Adults: A Systematic Review.二甲双胍用于治疗亚洲成年人2型糖尿病：一项系统评价
Diabetes Metab Syndr Obes. 2025 Mar 26;18:873-904. doi: 10.2147/DMSO.S479889. eCollection 2025.
2
Pharmacokinetic and Pharmacodynamic Properties of Once-Weekly Insulin Efsitora Alfa in Japanese Patients with Type 2 Diabetes.每周一次的胰岛素efitora alfa在日本2型糖尿病患者中的药代动力学和药效学特性
Diabetes Ther. 2025 Mar;16(3):513-526. doi: 10.1007/s13300-025-01695-x. Epub 2025 Feb 10.
3
[Diabetes and migration (update 2023)].[糖尿病与移民（2023年更新）]
Wien Klin Wochenschr. 2023 Jan;135(Suppl 1):286-306. doi: 10.1007/s00508-023-02175-7. Epub 2023 Apr 20.
4
Health-Related Quality of Life and Healthcare Events in Patients with Monotherapy of Anti-Diabetes Medications.抗糖尿病药物单药治疗患者的健康相关生活质量与医疗事件
Healthcare (Basel). 2023 Feb 12;11(4):541. doi: 10.3390/healthcare11040541.
5
Metformin Use Is Associated with Decreased Mortality in COVID-19 Patients with Diabetes: Evidence from Retrospective Studies and Biological Mechanism.二甲双胍的使用与2型糖尿病合并COVID-19患者死亡率降低相关：来自回顾性研究的证据及生物学机制
J Clin Med. 2021 Aug 9;10(16):3507. doi: 10.3390/jcm10163507.
6
FBXW7 gene polymorphism is associated with type 2 diabetes in the Uygur population in Xinjiang, China.FBXW7 基因多态性与中国新疆维吾尔族 2 型糖尿病相关。
Hereditas. 2021 Aug 9;158(1):27. doi: 10.1186/s41065-021-00191-z.
7
Cardiovascular outcomes of antidiabetes medications by race/ethnicity: A systematic review and meta-analysis.抗糖尿病药物的种族/民族心血管结局：系统评价和荟萃分析。
J Diabetes Complications. 2021 Sep;35(9):107980. doi: 10.1016/j.jdiacomp.2021.107980. Epub 2021 Jun 27.
8
Efficacy of once-daily glucagon-like peptide-1 receptor agonist lixisenatide as an add-on treatment to basal insulin in Asian and white adults with type 2 diabetes mellitus: An individual-level pooled analysis of phase III studies.在亚洲和白种成年人 2 型糖尿病患者中，每日一次胰高血糖素样肽-1 受体激动剂利西那肽作为基础胰岛素的附加治疗的疗效：III 期研究的个体水平汇总分析。
J Diabetes Investig. 2021 Aug;12(8):1386-1394. doi: 10.1111/jdi.13504. Epub 2021 Feb 28.
9
SGLT2 Inhibitors as Add-On Therapy to Metformin for People with Type 2 Diabetes: A Review of Placebo-Controlled Trials in Asian versus Non-Asian Patients.钠-葡萄糖协同转运蛋白2抑制剂作为二甲双胍的附加疗法用于2型糖尿病患者：亚洲与非亚洲患者安慰剂对照试验的综述
Diabetes Metab Syndr Obes. 2020 Aug 5;13:2765-2779. doi: 10.2147/DMSO.S193528. eCollection 2020.
10
Clinical evidence and treatment requirements related to heart failure in type 2 diabetes mellitus.2型糖尿病中心力衰竭的临床证据及治疗要求
Chin Med J (Engl). 2020 May 20;133(10):1135-1137. doi: 10.1097/CM9.0000000000000732.

本文引用的文献

1
Glycaemic responses in Asian and non-Asian people with type 2 diabetes initiating insulin glargine 100 units/mL: A patient-level pooled analysis of 16 randomised controlled trials.亚洲和非亚洲 2 型糖尿病患者起始使用甘精胰岛素 100 单位/毫升后的血糖反应：16 项随机对照试验的患者水平汇总分析。
Diabetes Res Clin Pract. 2018 Jan;135:199-205. doi: 10.1016/j.diabres.2017.11.025. Epub 2017 Nov 24.
2
No disparity of the efficacy and all-cause mortality between Asian and non-Asian type 2 diabetes patients with sodium-glucose cotransporter 2 inhibitors treatment: A meta-analysis.亚洲和非亚洲 2 型糖尿病患者使用钠-葡萄糖共转运蛋白 2 抑制剂治疗的疗效和全因死亡率无差异：一项荟萃分析。
J Diabetes Investig. 2018 Jul;9(4):850-861. doi: 10.1111/jdi.12760. Epub 2017 Nov 13.
3
Meta-analysis and critical review on the efficacy and safety of alpha-glucosidase inhibitors in Asian and non-Asian populations.对α-葡萄糖苷酶抑制剂在亚洲和非亚洲人群中的疗效和安全性进行的荟萃分析和批判性评价。
J Diabetes Investig. 2018 Mar;9(2):321-331. doi: 10.1111/jdi.12711. Epub 2017 Aug 17.
4
Factors Related to the Glucose-Lowering Efficacy of Dipeptidyl Peptidase-4 Inhibitors: A Systematic Review and Meta-Analysis Focusing on Ethnicity and Study Regions.二肽基肽酶-4抑制剂降糖疗效的相关因素：一项聚焦种族和研究地区的系统评价与Meta分析
Clin Drug Investig. 2017 Mar;37(3):219-232. doi: 10.1007/s40261-016-0478-8.
5
Comparison of efficacy and safety of two starting insulin regimens in non-Asian, Asian Indian, and East Asian patients with type 2 diabetes: a post hoc analysis of the PARADIGM study.两种起始胰岛素治疗方案在非亚洲、亚洲印度裔和东亚2型糖尿病患者中的疗效与安全性比较：PARADIGM研究的事后分析
Diabetes Metab Syndr Obes. 2016 Aug 9;9:243-9. doi: 10.2147/DMSO.S104752. eCollection 2016.
6
Efficacy and safety of avandamet or uptitrated metformin treatment in patients with type 2 diabetes inadequately controlled with metformin alone: a multicenter, randomized, controlled trial.与单独使用二甲双胍治疗血糖控制不佳的2型糖尿病患者相比，使用文达敏或逐步增加剂量的二甲双胍治疗的疗效和安全性：一项多中心、随机、对照试验。
Chin Med J (Engl). 2015 May 20;128(10):1279-87. doi: 10.4103/0366-6999.156735.
7
Early therapy for type 2 diabetes in China.中国 2 型糖尿病的早期治疗。
Lancet Diabetes Endocrinol. 2014 Dec;2(12):992-1002. doi: 10.1016/S2213-8587(14)70136-6. Epub 2014 Sep 10.
8
Dipeptidyl peptidase-4 inhibitors as a third-line oral antihyperglycaemic agent in patients with type 2 diabetes mellitus: the impact of ethnicity.二肽基肽酶-4 抑制剂作为 2 型糖尿病患者的三线口服降糖药：种族的影响。
Int J Endocrinol. 2014;2014:354040. doi: 10.1155/2014/354040. Epub 2014 Aug 10.
9
Ethnic differences in insulin sensitivity, β-cell function, and hepatic extraction between Japanese and Caucasians: a minimal model analysis.日裔人群和白种人群间胰岛素敏感性、β细胞功能和肝摄取的种族差异：最小模型分析。
J Clin Endocrinol Metab. 2014 Nov;99(11):4273-80. doi: 10.1210/jc.2014-1724. Epub 2014 Aug 13.
10
Efficacy of dipeptidyl-peptidase-4 inhibitors and impact on β-cell function in Asian and Caucasian type 2 diabetes mellitus patients: A meta-analysis.二肽基肽酶-4抑制剂对亚洲和高加索2型糖尿病患者的疗效及对β细胞功能的影响：一项荟萃分析。
J Diabetes. 2015 May;7(3):347-59. doi: 10.1111/1753-0407.12196. Epub 2014 Sep 10.